NL Diagnóstica

NL Diagnóstica is a Brazilian company based in São Paulo, with over 30 years of experience in the diagnostic sector. The company specializes in developing and manufacturing diagnostic systems and medical devices, focusing on innovative and automated solutions for clinical analysis. Key products include the Coproplus and Coproplus Ultra systems for stool analysis, the V8 automated capillary electrophoresis system for analyzing human samples, and the Abrazo Point of Care hemostasis system for rapid coagulation testing. NL Diagnóstica also offers a highly regarded rapid COVID-19 test, approved by both the FDA and Brazil’s ANVISA regulatory agency. Operating under the BSI – ISO 13485 Medical Devices Quality Management standard, NL Diagnóstica emphasizes customer satisfaction through comprehensive support. The company serves a wide range of healthcare providers, including laboratories and hospitals, and acts as a distributor for global diagnostic brands in Brazil.

• Employees27